Modulation of murine lymphoma growth by MDP, MDP(D-D) and cyclophosphamide. 1. Inhibition of growth in vivo
- 1 January 1983
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 5 (3) , 219-227
- https://doi.org/10.1016/0192-0561(83)90059-0
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Macrophage-stimulating effect of a synthetic muramyl dipeptide and its adjuvant-active and -inactive analogs for the production of T-cell activating monokinesCellular Immunology, 1981
- Augmentation of mouse natural killer cell activity by muramyl dipeptide and its analogsCellular Immunology, 1981
- Prostaglandin inhibition of T-cell proliferation is mediated at two levelsCellular Immunology, 1981
- Central pyrogenic activity of muramyl dipeptide.The Journal of Experimental Medicine, 1980
- Opposite effects of the synthetic adjuvant N‐acetyl‐muramyl‐L‐alanyl‐D‐isoglutamine on the immune response in mice depending on experimental conditionsEuropean Journal of Immunology, 1980
- BIOCHEMICAL EVIDENCE FOR ACTIVATION OF GUINEA PIG MACROPHAGES BY MURAMYL DIPEPTIDE Biomedical Research, 1980
- Inhibitory and stimulatory effects of a synthetic glycopeptide (MDP) on the in vitro PFC response: Factors affecting the responseCellular Immunology, 1979
- The macrophage, target cell of the synthetic adjuvant muramyl dipeptideEuropean Journal of Immunology, 1978
- Total synthesis and adjuvant activity of bacterial peptidoglycan derivativesBiochemical and Biophysical Research Communications, 1975
- Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivativesBiochemical and Biophysical Research Communications, 1974